Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 27 | $6,768,647 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
03 Jun 2022 16:13 | GNCA | GENOCEA BIOSCIENCES Inc | DUVALL DIANTHA | CHIEF FINANCIAL OFFICER | 02 Jun 2022 | Sale | 1,355 | 0.06 | 81 | D |
03 Jun 2022 16:12 | GNCA | GENOCEA BIOSCIENCES Inc | FLECHTNER JESSICA BAKER | Chief Scientific Officer | 02 Jun 2022 | Sale | 1,578 | 0.06 | 95 | D |
03 Jun 2022 16:11 | GNCA | GENOCEA BIOSCIENCES Inc | CLARK WILLIAM D | President and CEO | 02 Jun 2022 | Sale | 4,023 | 0.06 | 241 | D |
02 Jun 2022 16:32 | GNCA | GENOCEA BIOSCIENCES Inc | SUMER JACQUELYN L | CHIEF LEGAL & COMPLIANCE OFF | 01 Jun 2022 | Sale | 2,500 | 0.0601 | 150 | D |
02 Jun 2022 16:31 | GNCA | GENOCEA BIOSCIENCES Inc | CLARK WILLIAM D | President and CEO | 31 May 2022 | Sale | 117,244 | 0.0617 | 7,234 | D |
01 Jun 2022 16:11 | GNCA | GENOCEA BIOSCIENCES Inc | SIBER GEORGE | Director | 27 May 2022 | Sale | 20,425 | 0.0653 | 1,334 | D |
26 May 2022 18:32 | GNCA | GENOCEA BIOSCIENCES Inc | WALKER PAUL EDWARD | 10% | 25 May 2022 | Sale | 4,445,093 | 0.0816 | 362,720 | I |
26 May 2022 18:32 | GNCA | GENOCEA BIOSCIENCES Inc | WALKER PAUL EDWARD | 10% | 24 May 2022 | Sale | 5,931,843 | 0.0654 | 387,943 | I |
26 May 2022 18:31 | GNCA | GENOCEA BIOSCIENCES Inc | SONSINI PETER W. | 10% | 25 May 2022 | Sale | 4,445,093 | 0.0816 | 362,720 | I |
26 May 2022 18:31 | GNCA | GENOCEA BIOSCIENCES Inc | SONSINI PETER W. | 10% | 24 May 2022 | Sale | 5,931,843 | 0.0654 | 387,943 | I |
26 May 2022 18:29 | GNCA | GENOCEA BIOSCIENCES Inc | SANDELL SCOTT D | 10% | 25 May 2022 | Sale | 4,445,093 | 0.0816 | 362,720 | I |
26 May 2022 18:29 | GNCA | GENOCEA BIOSCIENCES Inc | SANDELL SCOTT D | 10% | 24 May 2022 | Sale | 5,931,843 | 0.0654 | 387,943 | I |
26 May 2022 18:26 | GNCA | GENOCEA BIOSCIENCES Inc | NEW ENTERPRISE ASSOCIATES 16, L.P. | 10% | 25 May 2022 | Sale | 4,445,093 | 0.0816 | 362,720 | D |
26 May 2022 18:26 | GNCA | GENOCEA BIOSCIENCES Inc | NEW ENTERPRISE ASSOCIATES 16, L.P. | 10% | 24 May 2022 | Sale | 5,931,843 | 0.0654 | 387,943 | D |
26 May 2022 18:25 | GNCA | GENOCEA BIOSCIENCES Inc | MAKHZOUMI MOHAMAD | 10% | 25 May 2022 | Sale | 4,445,093 | 0.0816 | 362,720 | I |
26 May 2022 18:25 | GNCA | GENOCEA BIOSCIENCES Inc | MAKHZOUMI MOHAMAD | 10% | 24 May 2022 | Sale | 5,931,843 | 0.0654 | 387,943 | I |
26 May 2022 18:23 | GNCA | GENOCEA BIOSCIENCES Inc | FLORENCE ANTHONY A. JR. | 10% | 25 May 2022 | Sale | 4,445,093 | 0.0816 | 362,720 | I |
26 May 2022 18:23 | GNCA | GENOCEA BIOSCIENCES Inc | FLORENCE ANTHONY A. JR. | 10% | 24 May 2022 | Sale | 5,931,843 | 0.0654 | 387,943 | I |
26 May 2022 18:21 | GNCA | GENOCEA BIOSCIENCES Inc | CHANG CARMEN | 10% | 25 May 2022 | Sale | 4,445,093 | 0.0816 | 362,720 | I |
26 May 2022 18:21 | GNCA | GENOCEA BIOSCIENCES Inc | CHANG CARMEN | 10% | 24 May 2022 | Sale | 5,931,843 | 0.0654 | 387,943 | I |
26 May 2022 18:19 | GNCA | GENOCEA BIOSCIENCES Inc | BEHBAHANI ALI | Director , 10% | 25 May 2022 | Sale | 4,445,093 | 0.0816 | 362,720 | I |
26 May 2022 18:19 | GNCA | GENOCEA BIOSCIENCES Inc | BEHBAHANI ALI | Director , 10% | 24 May 2022 | Sale | 5,931,843 | 0.0654 | 387,943 | I |
26 May 2022 18:16 | GNCA | GENOCEA BIOSCIENCES Inc | BASKETT FOREST | 10% | 25 May 2022 | Sale | 4,445,093 | 0.0816 | 362,720 | I |
26 May 2022 18:16 | GNCA | GENOCEA BIOSCIENCES Inc | BASKETT FOREST | 10% | 24 May 2022 | Sale | 5,931,843 | 0.0654 | 387,943 | I |
26 May 2022 16:15 | GNCA | GENOCEA BIOSCIENCES Inc | STAPLETON RAYMOND D JR | CHIEF TECHNOLOGY OFFICER | 25 May 2022 | Sale | 2,500 | 0.089 | 222 | D |
26 May 2022 16:13 | GNCA | GENOCEA BIOSCIENCES Inc | FLECHTNER JESSICA BAKER | Chief Scientific Officer | 25 May 2022 | Sale | 16,525 | 0.0881 | 1,456 | D |
26 May 2022 16:11 | GNCA | GENOCEA BIOSCIENCES Inc | DUVALL DIANTHA | CHIEF FINANCIAL OFFICER | 26 May 2022 | Sale | 24,407 | 0.0765 | 1,867 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)